Relx Plc (NYSE:RELX) Position Boosted by Signaturefd LLC

Signaturefd LLC grew its holdings in shares of Relx Plc (NYSE:RELX) by 2.7% in the 1st quarter, HoldingsChannel.com reports. The firm owned 39,593 shares of the technology company’s stock after purchasing an additional 1,029 shares during the period. Signaturefd LLC’s holdings in Relx were worth $1,996,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Golden State Wealth Management LLC boosted its position in shares of Relx by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock valued at $30,000 after purchasing an additional 294 shares in the last quarter. Cornerstone Planning Group LLC boosted its position in shares of Relx by 325.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock valued at $37,000 after purchasing an additional 530 shares in the last quarter. Transce3nd LLC bought a new position in shares of Relx during the 4th quarter valued at about $40,000. Brown Brothers Harriman & Co. boosted its position in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock valued at $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Redwood Investments LLC bought a new position in shares of Relx during the 4th quarter valued at about $120,000. Institutional investors own 15.02% of the company’s stock.

Relx Price Performance

RELX stock opened at $53.90 on Tuesday. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a one year low of $43.45 and a one year high of $56.33. The firm has a market capitalization of $98.99 billion, a PE ratio of 28.98, a P/E/G ratio of 3.23 and a beta of 0.83. The firm has a 50-day moving average of $53.74 and a two-hundred day moving average of $50.95.

Analysts Set New Price Targets

Several research firms have recently weighed in on RELX. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Saturday. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a research note on Wednesday, March 26th. They set a “buy” rating for the company. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.